If there is such a thing as a poster child for volatility in the stock market, the biotech sector would likely take top honors.Biotech stocks are unique. While stocks in other sectors are typically valued based on their past performance and future earnings potential, the majority of biotech stocks don’t have a cent in recurring revenue. Instead, biotech stocks are […]
Related BIIBMid-Day Market Update: U.S. Stocks Slide; Marketo Shares Surge On Earnings BeatMarket Update: Friday’s Mid-Day Market Movers: Amazon Shocks The Markets; Anthem, Cigna, StanCorp, PandoraThe Weekender(Seeking Alpha)Related SNSSMarket Update: Friday’s Mid-Day Market Movers: Amazon Shocks The Markets; Anthem, Cigna, StanCorp, PandoraWorst Performing Industries For July 24, 2015The Weekender(Seeking Alpha)Biotech stocks are plummeting broadly on Friday trading, after Biogen Inc […]
SummaryOvaScience, Sarpeta Therapeutics, Ziopharm Oncology and Keryx Biopharmaceuticals all have a short interest above 20%.
These small cap biotech companies provide attractive characteristics for fundamental weakness through liquidity needs, no revenue and a higher fail rate.
Given these common variables, there is strong indication that a large Marco short strategy has been put in place.
This large short position provides opportunities for contrarian […]
Kyle Anderson: Spending on cancer treatment has been skyrocketing globally. According to the IMS Institute of Health, spending on cancer topped $100 billion globally in 2014. That was a 10% increase from 2013.That’s why many biotech stocks tied to cancer treatments have seen triple-digit gains in the last two years.Have you ever wondered how billionaires continue to get RICHER, while the rest of […]
By Ben LevisohnSunTrust Robinson Humphrey’s Edward Nash and team offer five biotech stocks for the next six months:
Cempra (CEMP) ($50 PT), our top pick based on near-term clinical and commercial success potential. We recently met with management and it was reiterated that the second Phase III study of solithromycin in CABP (SOLITAIRE-IV) remains on track to report top-line data by […]
Updated 6/10 Biotech ETFs lag overall in 1.4% rally. Materials, financials and technology lead. Large cap biotechs doing well.
Rayno portfolio winners today: ALXN, BIIB, GILD, RHHBY etc
Rapid Fire Re-Balancing of ETFs into More Speculative Names
Is the Tail Wagging the Dog?
We have published a number of reports on Life Science ETFs (2/4/15) in the past and noticed changes lately that reflect a […]
Immunogen (NASDAQ:IMGN)Shares of Immunogen soared as much as 68% on June 1, 2015 after the company reported positive results in patients with platinum-resistant ovarian cancer. There are about 21,290 cases of women who get ovarian cancer in the United States each year. The problem is that a lot of these patients that take chemotherapy treatments such as platinum and paclitaxel […]
By Ben LevisohnRBC’s Michael Yee and team aren’t too worried about biotech stocks like Gilead Sciences (GILD), Celgene (CELG), and Biogen Idec (BIIB) despite the biotech sector’s big drop last week:
Biotech felt another volatile pullback (similar to March) in the last week of April, pulling back 9% in a week. Investors had their helmets on as we went right through […]
Related BIIBBiogen Continues To Decline After Friday’s RoutDid The AAN Meeting Affect Biogen, PTC Therapeutics, GW Pharma Or Isis Pharma?Synageva Q1 Loss Narrower-than-Expected, Pipeline in Focus – Analyst Blog(Zacks)In this week’s episode, Estimize is joined by Joe McCann, a former biotech analyst at CR Intrinsic and the CEO of Slingshot Insights.In the episode, Joe discusses Biogen Inc (NASDAQ: BIIB) new […]
Related CNCOppenheimer Boosting Targets In Healthcare On ‘Exposure To Interest Rate Changes’8 Managed Care Stocks To Watch In Earnings Season’Non-Cyclical Consumer Healthcare’: How This Sector Will Create Long-Term Wealth(Seeking Alpha)Related Biotech: Anatomy Of An Investing Mania?Bind Therapeutics Rallies Off Oppenheimer RatingIn separate reports, Oppenheimer analysts commented on the pipelines of two Biotech majors – Centene Corp (NYSE: CNC) and BIND […]